Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jul-Sep;13(3):264-266.
doi: 10.4103/apc.APC_116_19. Epub 2020 Jun 29.

Flecainide intoxication in pediatric patients with supraventricular tachycardia

Guiem Vaquer  1 , Laura Marfil  2 , Josep Ortega  2 , Anna Sabaté-Rotés  3 , Ferran Gran-Ipiña  3 , Ferran Roses-Noguer  3   4
Affiliations
Case Reports

Flecainide intoxication in pediatric patients with supraventricular tachycardia

Guiem Vaquer et al. Ann Pediatr Cardiol. 2020 Jul-Sep.

Abstract

Flecainide is a class IC antiarrhythmic indicated for ventricular and supraventricular arrhythmias in pediatric patients without structural heart disease. Flecainide has a narrow therapeutic window and proarrhythmic effect even in therapeutic doses and could lead to a life-threatening intoxication. Dosage errors, accidental intakes, and drug or food interactions, especially with dairy products, can be the cause of the intoxication. We report three consecutive cases of flecainide intoxication in children with supraventricular tachycardia (SVT) in our hospital from 2017 to 2019. Two cases had complete and spontaneous normalization of electrocardiogram (ECG) after flecainide removal. However, admission to the intensive care was required due to a sustained ventricular tachycardia in one case. Flecainide intoxication can be a life-threatening complication in patients with SVT. We believe all children should have close monitoring with serial ECG and plasma levels of flecainide during the 48-72 h after initiation of treatment, and consider hospitalization for patients <1 year of age.

Keywords: Arrhythmia; children; flecainide; intoxication; supraventricular tachycardia.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Electrocardiogram on admission and after normalization of alterations for case 2. (a) Electrocardiogram showed sinus rhythm with prolonged PR interval (174 ms), complete right bundle branch block (QRS of 174 ms), and prolonged QTc interval (518 ms). (b) Electrocardiogram after flecainide removal
Figure 2
Figure 2
Electrocardiogram on admission (a) during a ventricular tachycardia episode (b) and after 36 h of admission (c) in case 3. (a) Sinus bradycardia with a second-degree atrioventricular block and right bundle branch block. (b) Sudden change of morphology noted after forth beat with a sustained monomorphic ventricular tachycardia with a right bundle branch block morphology and superior axis
See this image and copyright information in PMC

References

    1. Brugada J, Blom N, Sarquella-Brugada G, Blomstrom-Lundqvist C, Deanfield J, Janousek J, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace. 2013;15:1337–82. - PubMed
    1. Köppel C, Oberdisse U, Heinemeyer G. Clinical course and outcome in class IC antiarrhythmic overdose. J Toxicol Clin Toxicol. 1990;28:433–44. - PubMed
    1. Perry JC, Garson A., Jr Flecainide acetate for treatment of tachyarrhythmias in children: Review of world literature on efficacy, safety, and dosing. Am Heart J. 1992;124:1614–21. - PubMed
    1. Thompson B, Mangat J, Barton C, et al. Decreased milk drinking causing flecainide toxicity in an older child. Case Reports. 2012:2012. bcr0220125810. - PMC - PubMed
    1. Close BR, Banks CJ. Pediatric flecainide toxicity from a double dose. Am J Emerg Med. 2012;30:2095e1–2. - PubMed

Publication types